Aurobindo Pharma has announced that the company has received final approval from the US Food and Drug Administration (US FDA) to manufacture and market Flecainide Acetate Tablets USP 50 mg, 100 mg and 150 mg (ANDA 202821). The company will commence shipping shortly.